214 related articles for article (PubMed ID: 2315430)
1. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
[TBL] [Abstract][Full Text] [Related]
2. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
[TBL] [Abstract][Full Text] [Related]
3. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
Lehmann LS; Bowden CL; Redmond FC; Stanton BC
Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
[TBL] [Abstract][Full Text] [Related]
4. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
Monteleone P; Fabrazzo M
Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
[TBL] [Abstract][Full Text] [Related]
5. The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.
Burch JE
Psychopharmacology (Berl); 1983; 80(3):254-8. PubMed ID: 6412270
[TBL] [Abstract][Full Text] [Related]
6. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
[TBL] [Abstract][Full Text] [Related]
7. Amitriptyline nortriptyline plasma levels and therapeutic response in depressed women.
Corona GL; Fenoglio L; Pinelli P; Zerbi F
Pharmakopsychiatr Neuropsychopharmakol; 1977 Dec; 10(6):299-308. PubMed ID: 360244
[No Abstract] [Full Text] [Related]
8. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
Vandel S; Bertschy G; Jounet JM; Allers G
Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels, psychophysiological variables, and clinical response to amitriptyline.
Breyer-Pfaff U; Gaertner HJ; Giedke H
Psychiatry Res; 1982 Apr; 6(2):223-34. PubMed ID: 6953461
[TBL] [Abstract][Full Text] [Related]
10. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.
Vandel S; Vandel B; Sandoz M; Allers G; Bechtel P; Volmat R
Eur J Clin Pharmacol; 1978 Nov; 14(3):185-90. PubMed ID: 365538
[TBL] [Abstract][Full Text] [Related]
11. Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline.
Baumann P; Jonzier-Perey M; Koeb L; Lê PK; Tinguely D; Schöpf J
Int Clin Psychopharmacol; 1986 Apr; 1(2):89-101. PubMed ID: 3571944
[TBL] [Abstract][Full Text] [Related]
12. [Relation of plasma amitriptyline and nortriptyline levels to the therapeutic response in endogenous depression].
Garaj V; Frank V; Drímalová M; Móric R; Pullmann R
Cesk Psychiatr; 1986 Oct; 82(5):307-12. PubMed ID: 3791462
[No Abstract] [Full Text] [Related]
13. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
Jungkunz G; Kuss HJ
Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
[TBL] [Abstract][Full Text] [Related]
14. Amitriptyline and nortriptyline plasma levels monitoring. Perspective in clinical practice.
Corona GL; Zerbi F; Pinelli P; Fenoglio L; Frattini P; Cucchi ML; Santagostino G
Commun Psychopharmacol; 1980; 4(4):309-16. PubMed ID: 7273704
[No Abstract] [Full Text] [Related]
15. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
Miljković B; Pokrajac M; Timotijević I; Varagić V
Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
[TBL] [Abstract][Full Text] [Related]
16. Treating delusional depressives with amitriptyline.
Spiker DG; Dealy RS; Hanin I; Weiss JC; Kupfer DJ
J Clin Psychiatry; 1986 May; 47(5):243-6. PubMed ID: 3516978
[TBL] [Abstract][Full Text] [Related]
17. Serum levels and response to amitriptyline in depressed out-patients.
Rowan PR; Paykel ES; Marks V; Mould G; Bhat A
Neuropsychobiology; 1984; 12(1):9-15. PubMed ID: 6514181
[TBL] [Abstract][Full Text] [Related]
18. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.
Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R
Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544
[TBL] [Abstract][Full Text] [Related]
19. Symptoms as predictors of response to amitriptyline and nortriptyline -- the plasma level variable.
Coryell W; Ziegler VE; Biggs JT
J Affect Disord; 1980 Mar; 2(1):27-35. PubMed ID: 6448878
[TBL] [Abstract][Full Text] [Related]
20. Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?
Gaertner HJ; Kreuter F; Scharek G; Wiatr G; Breyer-Pfaff U
Psychopharmacology (Berl); 1982; 76(3):236-9. PubMed ID: 6808543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]